CWM
EW icon

Crowley Wealth Management’s Edwards Lifesciences EW Stock Holding History

Crowley Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-352
Closed -$27.4K – 124
2025
Q3 		$27.4K Hold
352
– – 0.02% 196
2025
Q2 		$27.5K Hold
352
– – 0.03% 179
2025
Q1 		$25.5K Hold
352
– – 0.02% 180
2024
Q4 		$26.1K Buy
+352
New +$24.6K 0.02% 181

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Crowley Wealth Management's EW Position: Q4 2025 in Review

Crowley Wealth Management sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 352 shares — an estimated $27.4K sold.

Crowley Wealth Management first reported a position in EW in Q4 2024 and held it in 4 quarters. The position peaked at $27.5K in Q2 2025. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Crowley Wealth Management reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 352 Edwards Lifesciences shares in Q4 2025, an estimated $27.4K.
  • Crowley Wealth Management first reported a position in Edwards Lifesciences in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's Edwards Lifesciences position peaked at $27.5K in Q2 2025.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.